Results 261 to 270 of about 5,023,895 (307)

Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen. [PDF]

open access: yesEur J Haematol
Rowe M   +21 more
europepmc   +1 more source

Tumor Lysis Syndrome

Advances in Chronic Kidney Disease, 2021
Tumor lysis syndrome (TLS) is an oncologic emergency due to massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation.
Tarek Barbar
exaly   +4 more sources

Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency

open access: yesExpert Review of Hematology, 2016
Tumor lysis syndrome (TLS) is a rare but potentially life-threatening complication of neoplasms, preferentially hematological malignancies. Well known since at least ninety years ago, this condition can be misdiagnosed and incorrectly managed due to ...
Livio Pagano, Luana Fianchi
exaly   +3 more sources

Managing tumor lysis syndrome.

open access: yesJAAPA, 2020
Tumor lysis syndrome (TLS) is one of the most common oncologic emergencies, occurring when tumor cell contents are rapidly released into the bloodstream.
Chloe Greguska
semanticscholar   +4 more sources

Tumor Lysis Syndrome

Clinical Journal of Oncology Nursing, 2004
Tumor lysis syndrome (TLS) is an oncologic emergency characterized by electrolyte and metabolic disturbances that most commonly are associated with lymphoproliferative malignancies and chemotherapy administration. It is manifested by hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia.
Diane Cope, Jeannine M. Brant
  +6 more sources

Understanding tumor lysis syndrome

Intensive Care Medicine, 2019
L. Zafrani, E. Canet, M. Darmon
semanticscholar   +3 more sources

A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome [PDF]

open access: yesInternal Medicine, 2010
A 33-year-old man presented with pain and palsy of the leg in 2008 for treatment of hepatocellular carcinoma with huge distant metastases. The patient's tumors had slowly enlarged despite several treatments. Oral administration of sorafenib at 800 mg/day
Takeji Umemura   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy